Mergers & Acquisitions - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

26 to 50 of 259 results

bluebird bio acquires Precision Genome Engineering

01-07-2014

US clinical-stage gene therapies firm bluebird bio says it has acquired Precision Genome Engineering,…

Biotechnologybluebird bioMergers & AcquisitionsPrecision Genome Engineering

BioAlliance and Topotarget progress merger plan

BioAlliance and Topotarget progress merger plan

01-07-2014

France-base BioAlliance Pharma and Denmark’s Topotarget say that the shareholders of both companies…

BioAlliance PharmaBiotechnologyMergers & AcquisitionsOncologyOnxeoTopotarget

Roche invests in Stratos Genomics for “Sequencing by Expansion”

Roche invests in Stratos Genomics for “Sequencing by Expansion”

26-06-2014

Swiss pharma major Roche has made a strategic investment in USA-based Stratos Genomics and entered into…

BiotechnologyMergers & AcquisitionsResearchRocheStratos Genomics

Pharma and biotech sector leads the way in global M&A deals

Pharma and biotech sector leads the way in global M&A deals

20-06-2014

The pharma, medical and biotech industry is the most active sector for mergers and acquisitions so far…

BiotechnologyEuropeMergers & AcquisitionsPharmaceutical

Ablynx wins award for AbbVie deal at European Mediscience Awards

Ablynx wins award for AbbVie deal at European Mediscience Awards

20-06-2014

Belgian drug developer Ablynx has won the Transaction of the Year Award for its deal with US drugmaker…

AbbVieAblynxBelgiumBiotechnologyMergers & Acquisitions

Teva ready to pay up to $825 million for Labrys Biologics, and its novel migraine treatment

Teva ready to pay up to $825 million for Labrys Biologics, and its novel migraine treatment

03-06-2014

Israel generics giant Teva Pharmaceutical Industries has entered into a definitive agreement to acquire…

AmgenBiotechnologyLabrys BiologicsLBR-101Mergers & AcquisitionsNeurologicalTeva Pharmaceutical Industries

Definitive merger plan between BioAlliance Pharma and Topotarget

Definitive merger plan between BioAlliance Pharma and Topotarget

22-05-2014

French orphan drug developer BioAlliance Pharma and Denmark’s Topotarget have confirmed details of…

BioAlliance PharmaBiotechnologyMergers & AcquisitionsOncologyOnxeoTopotarget

Ventrus Biosciences boosted on merger plan with Assembly Pharma

19-05-2014

USA-based Ventrus Biosciences saw its shares leap 9.4% to $1.16 in pre-market trading, as it announced…

Anti-viralsAssembly BiosciencesAssembly PharmaceuticalsBiotechnologyMergers & AcquisitionsVentrus Biosciences

Lundbeck in deal to acquire Chelsea Therapeutics

Lundbeck in deal to acquire Chelsea Therapeutics

08-05-2014

Danish CNS specialist Lundbeck revealed today that it has entered into a definitive agreement to acquire…

BiotechnologyChelsea TherapeuticsLundbeckMergers & AcquisitionsNeurologicalNorthera

Bristol-Myers acquires iPierian for $175 million upfront, plus $550 possible milestones

Bristol-Myers acquires iPierian for $175 million upfront, plus $550 possible milestones

30-04-2014

US pharma major Bristol-Myers Squibb has acquired iPierian, a privately held biotechnology company focused…

BiotechnologyBristol-Myers SquibbiPierianIPN007Mergers & AcquisitionsNeurological

Hyperion Therapeutics to broaden orphan disease pipeline with buy of Israeli firm

24-04-2014

US biotech firm Hyperion Therapeutics has entered into a definitive agreement to acquire Andromeda Biotech,…

Andromeda BiotechBiotechnologyDiabetesDiaPep277Hyperion TherapeuticsMergers & Acquisitions

Sanofi divests Cell Therapy and Regenerative Medicine business to Aastrom

22-04-2014

US cardiovascular drug developer Aastrom Biosciences has entered into a definitive agreement to acquire…

Aastrom BiosciencesBiotechnologyMergers & AcquisitionsSanofi

Epirus to acquire Zalicus, creating a publicly-traded biosimilars enterprise

16-04-2014

Boston-based privately-held Epirus Biopharmaceuticals, focused on the global development and commercialization…

BiosimilarsBiotechnologyEPIRUS BiopharmaceuticalsMergers & AcquisitionsZalicus

Bio-Techne to acquire China’s PrimeGene

15-04-2014

Techne Corp (d/b/a Bio-Techne) says that its R&D Systems China subsidiary has entered into an agreement…

Bio-TechneBiotechnologyMergers & AcquisitionsPrimeGene Bio-Tech

NeoStem to acquire California Stem Cell, expanding pipeline

14-04-2014

USA-based NeoStem has entered into a definitive agreement to acquire California Stem Cell, an Irvine,…

BiotechnologyCalifornia Stem Cellmelapuldencel-TMergers & AcquisitionsNeoStemOncologyResearch

Roche in deal with Oryzon to develop epigenetics-based medicines; Buys IQuum

Roche in deal with Oryzon to develop epigenetics-based medicines; Buys IQuum

07-04-2014

Swiss drug major Roche has entered to a worldwide collaboration with Spanish functional genomics firm…

BiotechnologyIQuumLicensingMergers & AcquisitionsOncologyORY-1001Oryzon GenomicsRoche

Baxter to acquire Chatham Therapeutics for $70 million

03-04-2014

USA-based Baxter International says it has agreed to acquire Chatham Therapeutics, a private biotechnology…

Baxter InternationalBiotechnologyChatham TherapeuticsHematologyMergers & Acquisitions

Second collaboration between FORMA Therapeutics and Celgene

02-04-2014

Privately-held drug discovery firm FORMA Therapeutics has entered a second strategic collaboration and…

BiotechnologyCelgeneFORMA TherapeuticsLicensingMergers & AcquisitionsResearch

Tiziana Pharma plans listing via reverse takeover

Tiziana Pharma plans listing via reverse takeover

31-03-2014

Tiziana Pharma, a recently-established UK biotech company that has licensed technology for a potential…

BiotechnologyMergers & AcquisitionsOncologyTiziana

Intrexon acquires operations from Codexis and expands presence to Europe

17-03-2014

US synthetic biology firm Intrexon has acquired state-of-the-art laboratory operations in Budapest, Hungary,…

BiotechnologyCodexisEastern EuropeIntrexonMergers & AcquisitionsProduction

Galapagos sells service operations to Charles River for up to 34 million euros

Galapagos sells service operations to Charles River for up to 34 million euros

14-03-2014

Belgian biotech firm Galapagos has signed a definitive agreement to sell the BioFocus and Argenta service…

ArgentaBiotechnologyCharles River LaboratoriesGalapagosMergers & Acquisitions

Islet Sciences to acquire BHV Pharma along with diabetes and NASH products

Islet Sciences to acquire BHV Pharma along with diabetes and NASH products

13-03-2014

US biotech firm Islet Sciences says it has signed a binding letter of intent to acquire Brighthaven Ventures…

BiotechnologyDiabetesIslet SciencesMergers & AcquisitionsNephrology and Hepatologyremogliflozin

Sustainability of sky-high M&A valuations will be the biggest question for 2014, says new report

12-03-2014

The cautious optimism of 2012 turned into a fully fledged biotech boom in 2013, marked by surging company…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

26 to 50 of 259 results

Back to top